How much funding has XDemics raised?

XDemics has disclosed $14.8M raised across 3 rounds.

Where is XDemics headquartered?

XDemics is headquartered in Novato, US.

XDemics

Novato, US · Delaware corporation

XDemics builds Expansify cell culture plates that use a gas-permeable material and geometric design to enable high-density growth of T cells, viral vectors, stem cells, proteins, and organoids at yields far above conventional cultureware. Its ANSI/SLAS-footprint, liquid-handler-compatible formats serve cell therapy and bioprocessing research and production workflows with linear scaleup from lab plates to bioreactors.

BiotechHardwareHealthtech

Founders & leadership

Christopher ThanosinExecutive

Board

Colin CookinBoard director

Nicole BergmaninBoard director

Reported raises · per SEC filings

Form D private placements

$14.8M disclosed across 3 rounds · 2024–2025

▶$7.4MraisedFeb 2026 · 1 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Nicole BergmanDirector
Colin CookDirector
Christopher ThanosExecutive Officer, Director

Offering amount: $7.4M
Amount sold: $7.4M
First sale: Oct 2025
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$5.5MraisedDec 2024 · 3 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Nicole BergmanDirector
Colin CookDirector
Christopher ThanosExecutive Officer, Director

Offering amount: $7.6M
Amount sold: $5.5M
First sale: Nov 2024
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$1.9MraisedSep 2024 · 1 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Colin CookDirector
Christopher ThanosExecutive Officer, Director
Nicole BergmanDirector

Offering amount: $1.9M
Amount sold: $1.9M
First sale: May 2024
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

Molecular Devices18 shared keywordsMolecular Devices develops laboratory instruments and automated workflows for life science research, including SpectraMax microplate readers, high-content screening and imaging systems, colony-picking devices, and 3D organoid and cell culture solutions. It serves researchers in drug discovery, cell line development, and screening, supported by AI-enabled analysis software and GxP compliance tools.

Genomeweb9 shared keywordsGenomeWeb's Research Funding section publishes news coverage of research grants and government funding trends in genetics, genomics, and molecular diagnostics. It is an industry news publication serving researchers and organizations in the life sciences.

Companies competing with XDemics for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does XDemics do?: XDemics builds Expansify cell culture plates that use a gas-permeable material and geometric design to enable high-density growth of T cells, viral vectors, stem cells, proteins, and organoids at yields far above conventional cultureware. Its ANSI/SLAS-footprint, liquid-handler-compatible formats serve cell therapy and bioprocessing research and production workflows with linear scaleup from lab plates to bioreactors.
How much funding has XDemics raised?: XDemics has disclosed $14.8M raised across 3 rounds.
Where is XDemics headquartered?: XDemics is headquartered in Novato, US.